Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

New strategy for synthesis of mercaptoundecahydrododecaborate derivatives via click chemistry: possible boron carriers and visualization in cells for neutron capture therapy.

Authors:
Mohamed E El-Zaria Hiroyuki Nakamura

Inorg Chem 2009 Dec;48(24):11896-902

Department of Chemistry, Faculty of Science, Gakushuin University, 1-5-1 Mejiro, Toshima-ku, Tokyo 171-8588, Japan.

A new method that utilizes the click cycloaddition reaction to functionalize B(12)H(11)SH(2-) (BSH) with organic molecules was investigated. S,S-Dipropargyl-SB(12)H(11)(-) (1) and S-propargyl-SB(12)H(11)(2-) (4) were prepared from [(CH(3))(4)N](2)B(12)H(11)SH and [(CH(3))(4)N](2)B(12)H(11)S(CH(2))(2)CN (2) with propargyl bromide, respectively. Compound 1 or 4 reacted with various azides with mediation by Cu(II) ascorbate to give the corresponding bis-triazolo BSH derivatives (1-) or monotriazole BSH derivatives (2-), respectively, in excellent yields. The click cycloaddition reaction is very useful not only for the synthesis of various BSH-containing organic compounds for boron neutron capture therapy (BNCT) but also for the visualization of boron clusters in cells. We succeeded in the click cycloaddition reaction of compound 1 with Alexa Fluor 488 azide dye and found that 1 accumulated not in the cytoplasm but in the nuclei of HeLa cells.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ic902033cDOI Listing
December 2009

Publication Analysis

Top Keywords

click cycloaddition
12
cycloaddition reaction
12
capture therapy
8
bsh derivatives
8
neutron capture
8
compound alexa
4
boron neutron
4
compound reacted
4
compounds boron
4
reacted azides
4
mediation cuii
4
reaction compound
4
azides mediation
4
bromide compound
4
propargyl bromide
4
s-propargyl-sb12h112- prepared
4
488 azide
4
ss-dipropargyl-sb12h11- s-propargyl-sb12h112-
4
prepared [ch34n]2b12h11sh
4
fluor 488
4

Keyword Occurance

Similar Publications

BMS Derivatives C7-Linked to β-Cyclodextrin and Hyperbranched Polyglycerol Retain Activity against R5-HIV-1NLAD8 Isolates and Can Be Deemed Potential Microbicides.

Authors:
Jaume Vilarrasa Elena Petit Lluís Bosch Anna M Costa Ignacio Rodríguez-Izquierdo Daniel Sepúlveda-Crespo M Angeles Muñoz-Fernández

ChemMedChem 2021 Apr 11. Epub 2021 Apr 11.

Hospital General Universitario Gregorio Maranon Servicio de Cardiologia, Laboratorio de Inmunobiologia Molecular, Dr Esquerdo 46, 28007, Madrid, SPAIN.

Amides from indole-3-glyoxylic acid and 4 - benzoyl-2-methyl-piperazine, which are related to entry inhibitors developed by Bristol-Myers Squibb (BMS), have been synthesized with aliphatic chains located at the C7 position of the indole ring. These spacers contain an azido group suitable for the well-known Cu(I)-catalyzed (3+2)-cycloaddition or an activated triple bond for the less known nucleophilic addition of thiols under physiological conditions. Reaction with polyols (β-cyclodextrin and hyperbranched polyglycerol) decorated with complementary click partners has afforded polyol-BMS-like conjugates that are not cytotoxic (TZM. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Equipping Natural Killer Cells with Cetuximab through Metabolic Glycoengineering and Bioorthogonal Reaction for Targeted Treatment of KRAS Mutant Colorectal Cancer.

Authors:
Xianwu Wang Xi Luo Yunpeng Tian Ting Wu Jian Weng Zhu Li Feng Ye Xuefei Huang

ACS Chem Biol 2021 Apr 8. Epub 2021 Apr 8.

Department of Chemistry and Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan 48824, United States.

While Cetuximab can be used to treat KRAS wild-type colon cancer cells by targeting EGFR and inhibiting the activation of downstream signaling pathways, it exhibits little therapeutic effect on KRAS mutant colon cancer cells. Natural killer (NK) cells are a class of powerful immune cells with anticancer activities. However, NK cells typically lack inherent tumor targeting abilities. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

CEBA: A New Heterobifunctional Reagent for plasmid DNA functionalization by click chemistry.

Authors:
Haifei Gao Cristine Gonçalves Delphine Maze Chantal Pichon Patrick Midoux

Int J Pharm 2021 Apr 1:120566. Epub 2021 Apr 1.

Centre de Biophysique Moléculaire, CNRS UPR4301, Inserm and University of Orléans, F-45071, Orléans cedex 02, France. Electronic address:

Here, we report the synthesis of 3,6,9-trioxaundecan-1-{4-[(2-Chloroethyl)Ethylamino)]-Benzylamino},11-Azide (CEBA). CEBA alkylates the N7 of guanine of DNA thanks its chloroethyl group and can be coupled by a strain-promoted azide-alkyne cycloaddition to an alkynylated molecule. The optimization of the alkylation level of pDNA reveals that the expression of the encoded gene is preserved when it is randomly modified with at most 1 CEBA molecule per 150 bp. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection.

Authors:
Jutamas Jiaranaikulwanitch Hataichanok Pandith Sarin Tadtong Phanit Thammarat Supat Jiranusornkul Nattapong Chauthong Supitcha Nilkosol Opa Vajragupta

Molecules 2021 Mar 12;26(6). Epub 2021 Mar 12.

Office of Research Affairs, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

Alzheimer's disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap